- Home
- HAYW vs ADMA Comparison
HAYW vs ADMA Comparison
Compare HAYW & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAYW
- ADMA
- Stock Information
- Founded
- HAYW 1925
- ADMA 2004
- Country
- HAYW United States
- ADMA United States
- Employees
- HAYW N/A
- ADMA N/A
- Industry
- HAYW Electronic Components
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HAYW Technology
- ADMA Health Care
- Exchange
- HAYW Nasdaq
- ADMA Nasdaq
- Market Cap
- HAYW 3.1B
- ADMA 4.1B
- IPO Year
- HAYW 2021
- ADMA N/A
- Fundamental
- Price
- HAYW $14.15
- ADMA $18.43
- Analyst Decision
- HAYW Buy
- ADMA Strong Buy
- Analyst Count
- HAYW 4
- ADMA 4
- Target Price
- HAYW $16.83
- ADMA $22.50
- AVG Volume (30 Days)
- HAYW 2.1M
- ADMA 2.8M
- Earning Date
- HAYW 05-01-2025
- ADMA 03-03-2025
- Dividend Yield
- HAYW N/A
- ADMA N/A
- EPS Growth
- HAYW 45.95
- ADMA N/A
- EPS
- HAYW 0.54
- ADMA 0.81
- Revenue
- HAYW $1,051,606,000.00
- ADMA $426,454,000.00
- Revenue This Year
- HAYW $4.98
- ADMA $16.18
- Revenue Next Year
- HAYW $6.25
- ADMA $23.92
- P/E Ratio
- HAYW $26.22
- ADMA $22.78
- Revenue Growth
- HAYW 5.96
- ADMA 65.15
- 52 Week Low
- HAYW $11.96
- ADMA $5.88
- 52 Week High
- HAYW $16.87
- ADMA $23.64
- Technical
- Relative Strength Index (RSI)
- HAYW 45.74
- ADMA 61.93
- Support Level
- HAYW $13.61
- ADMA $17.64
- Resistance Level
- HAYW $15.14
- ADMA $18.62
- Average True Range (ATR)
- HAYW 0.50
- ADMA 1.13
- MACD
- HAYW -0.05
- ADMA 0.27
- Stochastic Oscillator
- HAYW 26.87
- ADMA 96.29
About HAYW Hayward Holdings Inc.
Hayward Holdings is a leading manufacturer of energy-efficient swimming pool equipment and pool automation systems. The company offers a wide range of pool equipment, including pumps, filters, heaters, LED lights, and sanitization. Headquartered in Charlotte, North Carolina, the company has around 2,000 full-time employees. Hayward generated approximately $1.0 billion in revenue in 2023.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.